BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
3.740
+0.040 (1.08%)
At close: Jun 24, 2026
BioStem Technologies Market Cap
BioStem Technologies has a market cap or net worth of $66.3 million as of June 24, 2026. Its market cap has decreased by -72.25% in one year.
Market Cap
66.30M
Enterprise Value
55.87M
Revenue
37.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.74
Market Cap Chart
Since August 4, 2009, BioStem Technologies's market cap has increased from 4.77M to 66.30M, an increase of 1,288.63%. That is a compound annual growth rate of 16.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 66.30M | 3.58% |
| Dec 31, 2025 | 64.01M | -72.22% |
| Dec 31, 2024 | 230.43M | 143.12% |
| Dec 29, 2023 | 94.78M | 160.66% |
| Dec 30, 2022 | 36.36M | 267.00% |
| Dec 30, 2021 | 9.91M | -25.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 132.95M |
| HST Global | 99.00M |
| NDT Pharmaceuticals | 91.20M |
| Sangamo Therapeutics | 72.29M |
| Cell Source | 53.15M |
| ProText Mobility | 48.35M |
| Vicapsys Life Sciences | 47.26M |
| Nuo Therapeutics | 43.80M |